All In Biotech

Drug Trial Radar · NCT07219511

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

42

Planned (sponsor's estimate)

Start

Nov 4, 2025

Primary completion

Nov 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Vasa TherapeuticsIndustry
Sponsor type
Industry
First posted
Oct 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

Conditions

  • Heart
  • Heart Failure With Preserved Ejection Fraction (HFPEF)

Interventions

  • VS-041Drug

    VS-041 high dose, VS-041 low dose or Placebo tablet BID

  • PlaceboOther

    Placebo to match VS-041

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Participant incidence of treatment-emergent adverse events (TEAEs)Time frame: From Baseline to Day 28
  2. Change from baseline over time in serum NordicPRO-C6Time frame: From Baseline to Day 28
  3. Change from baseline over time in serum endotrophinTime frame: From Baseline to Day 28
  4. Change from baseline over time in serum NT-proBNPTime frame: From Baseline to Day 28

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • Cardiology and Medicine Clinic

    Little Rock, Arkansas

  • National Institute of Clinical Research

    Huntington Beach, California

  • FOMAT

    Santa Maria, California

  • Invivocure LLC

    Van Nuys, California

  • New Generation of Medical Research

    Hialeah, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Amavita Health

    North Miami Beach, Florida

  • Broward Research Center

    Pembroke Pines, Florida

  • Eagle Clinical Research

    Chicago, Illinois

  • Chicago Medical Research

    Hazel Crest, Illinois

  • Methodist Medical Center of Illinois

    Peoria, Illinois

  • Louisiana Heart Center

    Slidell, Louisiana

  • Washington University

    St Louis, Missouri

  • Ash Research Clinic

    Brick, New Jersey

  • Erie County Medical Center

    Buffalo, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Wake Forest

    Winston-Salem, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Oklahoma Heart Hospital

    Oklahoma City, Oklahoma

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • LinQ Research, LLC

    Tomball, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.